229 related articles for article (PubMed ID: 28859103)
1. MYT1L mutations cause intellectual disability and variable obesity by dysregulating gene expression and development of the neuroendocrine hypothalamus.
Blanchet P; Bebin M; Bruet S; Cooper GM; Thompson ML; Duban-Bedu B; Gerard B; Piton A; Suckno S; Deshpande C; Clowes V; Vogt J; Turnpenny P; Williamson MP; Alembik Y; ; ; Glasgow E; McNeill A
PLoS Genet; 2017 Aug; 13(8):e1006957. PubMed ID: 28859103
[TBL] [Abstract][Full Text] [Related]
2. Nine newly identified individuals refine the phenotype associated with MYT1L mutations.
Windheuser IC; Becker J; Cremer K; Hundertmark H; Yates LM; Mangold E; Peters S; Degenhardt F; Ludwig KU; Zink AM; Lessel D; Bierhals T; Herget T; Johannsen J; Denecke J; Wohlleber E; Strom TM; Wieczorek D; Bertoli M; Colombo R; Hempel M; Engels H
Am J Med Genet A; 2020 May; 182(5):1021-1031. PubMed ID: 32065501
[TBL] [Abstract][Full Text] [Related]
3. Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity.
De Rocker N; Vergult S; Koolen D; Jacobs E; Hoischen A; Zeesman S; Bang B; Béna F; Bockaert N; Bongers EM; de Ravel T; Devriendt K; Giglio S; Faivre L; Joss S; Maas S; Marle N; Novara F; Nowaczyk MJ; Peeters H; Polstra A; Roelens F; Rosenberg C; Thevenon J; Tümer Z; Vanhauwaert S; Varvagiannis K; Willaert A; Willemsen M; Willems M; Zuffardi O; Coucke P; Speleman F; Eichler EE; Kleefstra T; Menten B
Genet Med; 2015 Jun; 17(6):460-6. PubMed ID: 25232846
[TBL] [Abstract][Full Text] [Related]
4. MYT1L is a candidate gene for intellectual disability in patients with 2p25.3 (2pter) deletions.
Stevens SJ; van Ravenswaaij-Arts CM; Janssen JW; Klein Wassink-Ruiter JS; van Essen AJ; Dijkhuizen T; van Rheenen J; Heuts-Vijgen R; Stegmann AP; Smeets EE; Engelen JJ
Am J Med Genet A; 2011 Nov; 155A(11):2739-45. PubMed ID: 21990140
[TBL] [Abstract][Full Text] [Related]
5. Early-onset obesity and paternal 2pter deletion encompassing the ACP1, TMEM18, and MYT1L genes.
Doco-Fenzy M; Leroy C; Schneider A; Petit F; Delrue MA; Andrieux J; Perrin-Sabourin L; Landais E; Aboura A; Puechberty J; Girard M; Tournaire M; Sanchez E; Rooryck C; Ameil A; Goossens M; Jonveaux P; Lefort G; Taine L; Cailley D; Gaillard D; Leheup B; Sarda P; Geneviève D
Eur J Hum Genet; 2014 Apr; 22(4):471-9. PubMed ID: 24129437
[TBL] [Abstract][Full Text] [Related]
6. A novel MYT1L mutation in a patient with severe early-onset obesity and intellectual disability.
Loid P; Mäkitie R; Costantini A; Viljakainen H; Pekkinen M; Mäkitie O
Am J Med Genet A; 2018 Sep; 176(9):1972-1975. PubMed ID: 30055078
[TBL] [Abstract][Full Text] [Related]
7. MYT1L mutation in a patient causes intellectual disability and early onset of obesity: a case report and review of the literature.
Al Tuwaijri A; Alfadhel M
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):409-413. PubMed ID: 30796847
[TBL] [Abstract][Full Text] [Related]
8. A novel MYT1L mutation in a boy with syndromic obesity: Case report and literature review.
Carvalho LML; D'Angelo CS; Mustacchi Z; da Silva IT; Krepischi ACV; Koiffmann CP; Rosenberg C
Obes Res Clin Pract; 2021; 15(2):124-132. PubMed ID: 33622623
[TBL] [Abstract][Full Text] [Related]
9. Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability.
Kasher PR; Schertz KE; Thomas M; Jackson A; Annunziata S; Ballesta-Martinez MJ; Campeau PM; Clayton PE; Eaton JL; Granata T; Guillén-Navarro E; Hernando C; Laverriere CE; Liedén A; Villa-Marcos O; McEntagart M; Nordgren A; Pantaleoni C; Pebrel-Richard C; Sarret C; Sciacca FL; Wright R; Kerr B; Glasgow E; Banka S
Am J Hum Genet; 2016 Feb; 98(2):363-72. PubMed ID: 26833329
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency of the MYT1L gene causes intellectual disability frequently associated with behavioral disorder.
Mayo S; Roselló M; Monfort S; Oltra S; Orellana C; Martínez F
Genet Med; 2015 Aug; 17(8):683-4. PubMed ID: 26240977
[No Abstract] [Full Text] [Related]
11. MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects.
Coursimault J; Guerrot AM; Morrow MM; Schramm C; Zamora FM; Shanmugham A; Liu S; Zou F; Bilan F; Le Guyader G; Bruel AL; Denommé-Pichon AS; Faivre L; Tran Mau-Them F; Tessarech M; Colin E; El Chehadeh S; Gérard B; Schaefer E; Cogne B; Isidor B; Nizon M; Doummar D; Valence S; Héron D; Keren B; Mignot C; Coutton C; Devillard F; Alaix AS; Amiel J; Colleaux L; Munnich A; Poirier K; Rio M; Rondeau S; Barcia G; Callewaert B; Dheedene A; Kumps C; Vergult S; Menten B; Chung WK; Hernan R; Larson A; Nori K; Stewart S; Wheless J; Kresge C; Pletcher BA; Caumes R; Smol T; Sigaudy S; Coubes C; Helm M; Smith R; Morrison J; Wheeler PG; Kritzer A; Jouret G; Afenjar A; Deleuze JF; Olaso R; Boland A; Poitou C; Frebourg T; Houdayer C; Saugier-Veber P; Nicolas G; Lecoquierre F
Hum Genet; 2022 Jan; 141(1):65-80. PubMed ID: 34748075
[TBL] [Abstract][Full Text] [Related]
12. MYT1L: A systematic review of genetic variation encompassing schizophrenia and autism.
Mansfield P; Constantino JN; Baldridge D
Am J Med Genet B Neuropsychiatr Genet; 2020 Jun; 183(4):227-233. PubMed ID: 32267091
[TBL] [Abstract][Full Text] [Related]
13. Germline mosaic transmission of a novel duplication of PXDN and MYT1L to two male half-siblings with autism.
Meyer KJ; Axelsen MS; Sheffield VC; Patil SR; Wassink TH
Psychiatr Genet; 2012 Jun; 22(3):137-40. PubMed ID: 22157634
[TBL] [Abstract][Full Text] [Related]
14. 2p25.3 microduplications involving MYT1L: further phenotypic characterization through an assessment of 16 new cases and a literature review.
Bouassida M; Egloff M; Levy J; Chatron N; Bernardini L; Le Guyader G; Tabet AC; Schluth-Bolard C; Brancati F; Giuffrida MG; Dard R; Clorennec J; Coursimault J; Vialard F; Hervé B
Eur J Hum Genet; 2023 Aug; 31(8):895-904. PubMed ID: 37188826
[TBL] [Abstract][Full Text] [Related]
15. A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.
Chen J; Lambo ME; Ge X; Dearborn JT; Liu Y; McCullough KB; Swift RG; Tabachnick DR; Tian L; Noguchi K; Garbow JR; Constantino JN; Gabel HW; Hengen KB; Maloney SE; Dougherty JD
Neuron; 2021 Dec; 109(23):3775-3792.e14. PubMed ID: 34614421
[TBL] [Abstract][Full Text] [Related]
16. A new patient with a terminal de novo 2p25.3 deletion of 1.9 Mb associated with early-onset of obesity, intellectual disabilities and hyperkinetic disorder.
Bonaglia MC; Giorda R; Zanini S
Mol Cytogenet; 2014; 7():53. PubMed ID: 25126114
[TBL] [Abstract][Full Text] [Related]
17. [Genetic diagnosis and analysis of related genes for a pedigree with 2p25 and 12p13 cryptic rearrangements].
Tu X; Zeng J; Cong X; Yan A; Lin Y; Zhang X; Qiu L; Zhou Y; Lan F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Aug; 31(4):444-8. PubMed ID: 25119907
[TBL] [Abstract][Full Text] [Related]
18. Complex Autism Spectrum Disorder in a Patient with a Novel De Novo Heterozygous
Yip S; Calli K; Qiao Y; Trost B; Scherer SW; Lewis MES
Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136944
[TBL] [Abstract][Full Text] [Related]
19. MYT1L variant inherited by a mosaic father in a case of severe developmental and epileptic encephalopathy.
Boeri S; Scala M; Madia F; Perucco F; Vozzi D; Capra V; Zara F; Nobili L; Mancardi MM
Epileptic Disord; 2023 Dec; 25(6):874-879. PubMed ID: 37518898
[TBL] [Abstract][Full Text] [Related]
20. Associations of the Intellectual Disability Gene MYT1L with Helix-Loop-Helix Gene Expression, Hippocampus Volume and Hippocampus Activation During Memory Retrieval.
Kepa A; Martinez Medina L; Erk S; Srivastava DP; Fernandes A; Toro R; Lévi S; Ruggeri B; Fernandes C; Degenhardt F; Witt SH; Meyer-Lindenberg A; Poncer JC; Martinot JL; Paillère Martinot ML; Müller CP; Heinz A; Walter H; Schumann G; Desrivières S
Neuropsychopharmacology; 2017 Dec; 42(13):2516-2526. PubMed ID: 28470180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
